TL
Insider
Trv Gp Iv, Llc
10% ownerTrv Gp Iv, Llc (10% owner) filed 4 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 4 sales), most often in Tango Therapeutics, Inc. (TNGX). The largest single filing was $5.1M of TNGX (729,365 sh across 2 lots, as filed), executed Sep 5 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$16.5M
shares × price, as filed
Last traded
Oct 23 2025
Filed Oct 27 2025
Median ADV $98.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $16.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 24 months
Most traded names
TNGXRecent filings
TNGXSALE
Tango Therapeutics, Inc.
View filing →
$4.8M477,401 sh × $10.15
Exec Oct 23 2025
Filed Oct 27 2025 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $4.0M
500,000 sh × $8.02
Exec Sep 25 2025
Filed Sep 29 2025 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $2.6M
363,541 sh × $7.04
Exec Sep 16 2025
Filed Sep 17 2025 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. View filing → $5.1M
729,365 sh across 2 lots
Exec Sep 5 2025
Filed Sep 9 2025 · 5:30 PM ET